diabetic eye disease therapeutic (Jenesis/Joslin Diabetes Center)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Namediabetic eye disease therapeutic (Jenesis/Joslin Diabetes Center)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsDiabetic eye disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesJenesis Biosciences LLC
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesJenesis Biosciences LLCJoslin Diabetes Center Inc
Active IndicationsN/A
Inactive IndicationsDiabetic eye disease

Other Information

ATC CodeN/A
Related LinksN/A